Puerarin prevents progression of experimental hypoxia-induced pulmonary hypertension via inhibition of autophagy

Pulmonary arterial hypertension (PAH) is defined as elevation of mean pulmonary arterial pressure to ≥25 mmHg within the low pressure pulmonary circulatory system. PAH is characterized by obstructive vascular remodeling, partially due to excessive pulmonary arterial smooth muscle cell (PASMC) prolif...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaodan Zhang (Author), Qi Liu (Author), Chen Zhang (Author), Jiejing Sheng (Author), Songlin Li (Author), Wendi Li (Author), Xinying Yang (Author), Xiaoying Wang (Author), Siyu He (Author), June Bai (Author), Daling Zhu (Author)
Format: Book
Published: Elsevier, 2019-10-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_f02eb9d4ab8b487ab9671e9a647e6ed1
042 |a dc 
100 1 0 |a Xiaodan Zhang  |e author 
700 1 0 |a Qi Liu  |e author 
700 1 0 |a Chen Zhang  |e author 
700 1 0 |a Jiejing Sheng  |e author 
700 1 0 |a Songlin Li  |e author 
700 1 0 |a Wendi Li  |e author 
700 1 0 |a Xinying Yang  |e author 
700 1 0 |a Xiaoying Wang  |e author 
700 1 0 |a Siyu He  |e author 
700 1 0 |a June Bai  |e author 
700 1 0 |a Daling Zhu  |e author 
245 0 0 |a Puerarin prevents progression of experimental hypoxia-induced pulmonary hypertension via inhibition of autophagy 
260 |b Elsevier,   |c 2019-10-01T00:00:00Z. 
500 |a 1347-8613 
500 |a 10.1016/j.jphs.2019.09.010 
520 |a Pulmonary arterial hypertension (PAH) is defined as elevation of mean pulmonary arterial pressure to ≥25 mmHg within the low pressure pulmonary circulatory system. PAH is characterized by obstructive vascular remodeling, partially due to excessive pulmonary arterial smooth muscle cell (PASMC) proliferation. Puerarin is a natural flavonoid isolated from the herb Radix puerariae, which has been widely used for the treatment of cardiovascular and cerebrovascular disorders and diabetes. However, how puerarin mediates autophagy in the progression of pulmonary vascular remodeling is unclear. In this study, we explored the effects of puerarin in a hypoxic pulmonary hypertension (PH) rat model using immunohistochemistry, and morphometric analyses of right ventricle. In addition, cell counting kit 8 assay, western blotting and flow cytometry were employed to test cell proliferation in PASMCs, and then autophagy was tested with mRFP-GFP-LC3 fluorescence microscopy and Western blot. We found that puerarin could alleviate hypoxia-induced PH in rats and improved pulmonary histopathology, and also reduced the expression of autophagy markers in vivo and in vitro. Moreover, puerarin also ameliorated hypoxia-induced PASMC proliferation in an autophagy-dependent manner. Overall, these findings demonstrated that puerarin could prevent hypoxia-induced PH in rats, possibly via reducing autophagy and suppressing cell proliferation. Keywords: Puerarin, Hypoxia, Pulmonary artery hypertension, Autophagy, Proliferation 
546 |a EN 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Journal of Pharmacological Sciences, Vol 141, Iss 2, Pp 97-105 (2019) 
787 0 |n http://www.sciencedirect.com/science/article/pii/S1347861319357135 
787 0 |n https://doaj.org/toc/1347-8613 
856 4 1 |u https://doaj.org/article/f02eb9d4ab8b487ab9671e9a647e6ed1  |z Connect to this object online.